CervoMed Inc.
CRVO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053691
No open-market purchases or sales by CervoMed Inc. insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $5.42M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in CervoMed Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 12
- +2 vs. Q2 2023
- Shares held
- 363.7K
- +187.0K (+105.8%) vs. Q2 2023
- Total value
- $1.68M
- +$1.09M (+185.1%) vs. Q2 2023
- New holders
- 4
- 0 more added
- Sold out
- 2
- 8 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRVO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 37 | $5.42M |
| Q1 2026 | 36 | $6.97M |
| Q4 2025 | 48 | $17.4M |
| Q3 2025 | 45 | $17.3M |
| Q2 2025 | 45 | $13.7M |
| Q1 2025 | 48 | $20.9M |
| Q4 2024 | 49 | $3.46M |
| Q3 2024 | 50 | $51.2M |
| Q2 2024 | 38 | $59.0M |
| Q1 2024 | 20 | $58.6M |
| Q4 2023 | 12 | $2.48M |
| Q3 2023 | 12 | $1.68M |
| Q2 2023 | 11 | $589.9K |
| Q1 2023 | 12 | $838.9K |
| Q4 2022 | 13 | $923.7K |
| Q3 2022 | 12 | $1.00M |
| Q2 2022 | 15 | $1.39M |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding CervoMed Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Adage Capital Partners GP, L.L.C. | 199,347 | $921.0K | 0.00% | +199,347 | New |
| Rock Springs Capital Management LP | 80,033 | $369.8K | 0.01% | +80,033 | New |
| Renaissance Technologies LLC | 29,233 | $135.0K | 0.00% | −11,076−27.5% | Reduced |
| BlackRock Inc. | 21,900 | $101.2K | 0.00% | −10,952−33.3% | Reduced |
| Vanguard Group Inc | 19,916 | $92.0K | 0.00% | −46,316−69.9% | Reduced |
| Geode Capital Management, LLC | 11,092 | $52.9K | 0.00% | −6,031−35.2% | Reduced |
| Hoey Investments, Inc | 1,080 | $4.99K | 0.00% | +1,080 | New |
| Advisor Group Holdings, Inc. | 395 | $1.82K | 0.00% | −199−33.5% | Reduced |
| Morgan Stanley | 364 | $1.68K | 0.00% | −184−33.6% | Reduced |
| Tower Research Capital LLC (TRC) | 296 | $1.37K | 0.00% | −2,114−87.7% | Reduced |
| Wells Fargo & Company | 10 | $46 | 0.00% | −5−33.3% | Reduced |
| Citigroup Inc | 1 | $5 | 0.00% | +1 | New |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −16,565−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −60−100.0% | Sold out |
| Coastal Capital Group, Inc. | – | – | – | – | Not filed |